FrancophonIA/ELRC3.0 huggingface dataset:
English: If your doctor tells you to increase your dose further, you will add one 200 microgram tablet to your morning dose and one 200 microgram tablet to your evening dose with each new step.
Danish: Hvis din læge fortæller dig, at du skal øge din dosis yderligere, skal du føje en 200 mikrogram-tablet til din morgendosis og en 200 mikrogram-tablet til din aftendosis ved hvert nye trin.
English: They are usually transient or manageable with symptomatic treatment (see section 4.8).
Danish: Bivirkningerne er som regel forbigående eller tålelige med symptomatisk behandling (se pkt.
English: Thyroid function tests
Danish: Thyroideafunktionstest
English: • Severe arrhythmias.
Danish: • Svære arytmier.
English: If you notice any of the above signs or your condition changes, tell your doctor immediately.
Danish: Fortæl det straks til lægen, hvis du bemærker et af ovenstående tegn, eller din tilstand forandres.
English: Exposure to selexipag and its active metabolite in these two subjects was similar to that in subjects with moderate (Child-Pugh class B) hepatic impairment.
Danish: Eksponeringen for selexipag og dets aktive metabolit hos disse to forsøgsdeltagere var ensartet med eksponeringen hos forsøgsdeltagere med moderat (Child-Pugh-klasse B) leverinsufficiens.
English: Treatment with selexipag resulted in a placebo-corrected median effect on 6MWD measured at trough (i.e., approximately 12 h post-dose) of 12 m at Week 26 (99% CI: 1, 24 m;
Danish: Behandling med selexipag resulterede i en placebokorrigeret medianvirkning på 6MWD målt ved laveste koncentration (dvs. 12 timer efter dosering) på 12 m ved uge 26 (99 % CI: 1, 24 m; enkeltsidet p-værdi = 0,0027).
English: With each step, you will add one 200 microgram tablet to your morning dose and another 200 microgram tablet to your evening dose.
Danish: Ved hvert trin føjer du en 200 mikrogram-tablet til din morgendosis og en 200 mikrogram-tablet til din aftendosis.
English: What you need to know before you take Uptravi
Danish: Det skal du vide, før du begynder at tage Uptravi Tag ikke Uptravi
English: Consequently, if signs of pulmonary oedema occur when Uptravi is administered in patients with PAH, the possibility of pulmonary veno-occlusive disease should be considered.
Danish: Som følge heraf skal der tages højde for muligheden for pulmonal veno-okklusiv sygdom, hvis der opstår tegn på lungeødem, når Uptravi administreres til patienter med PAH.
English: Talk to your PAH doctor or nurse if you are taking any of the following medicines: - Gemfibrozil (medicine used to lower the level of fats [lipids] in the blood) - Clopidogrel (medicine used to inhibit blood clots in coronary artery disease) - Deferasirox (medicine used to remove iron from the blood stream) - Teriflunomide (medicine used to treat relapsing-remitting multiple sclerosis) - Carbamazepine (medicine used to treat some forms of epilepsy, nerve pain or to help control serious mood disorders when some other medicines do not work) - Phenytoin (medicine used to treat epilepsy) - Valproic acid (medicine used to treat epilepsy) - Probenecid (medicine used to treat gout) - Fluconazole, rifampicin or rifapentine (antibiotics used to treat infections)
Danish: Fortæl det til din PAH-læge eller sundhedspersonalet, hvis du tager et eller flere af følgende lægemidler: - Gemfibrozil (lægemiddel, der anvendes til at sænke niveauet af fedt [lipider] i blodet) - Clopidogrel (lægemiddel, der anvendes til at hæmme dannelsen af blodpropper ved koronararteriesygdom) - Deferasirox (lægemiddel, der anvendes til at fjerne jern fra blodet) - Teriflunomid (lægemiddel, der anvendes til behandling af recidiverende-remitterende multipel sklerose) - Carbamazepin (lægemiddel, der anvendes til behandling af visse former for epilepsi,
English: Page 8
Danish: Side 8
English: The most commonly reported adverse reactions are headache, diarrhoea, nausea and vomiting, jaw pain, myalgia, pain in extremity, arthralgia, and flushing.
Danish: De mest almindeligt indberettede bivirkninger er hovedpine, diarré, kvalme og opkastning, smerter i kæben, myalgi, ekstremitetssmerter, artralgi og blussen.
English: During titration, you may experience side effects such as headache, diarrhoea, feeling sick (nausea), being sick (vomiting), jaw pain, muscle pain, leg pain, joint pain, or reddening of the face (see section 4).
Danish: I titreringsforløbet kan du få bivirkninger, såsom hovedpine, diarré, kvalme, opkastning, smerter i kæben, muskelsmerter, smerter i benene, ledsmerter eller ansigtsrødme (se afsnit 4).
English: - If you have any further questions, ask your doctor or nurse.
Danish: Er du i tvivl eller har spørgsmål, så spørg lægen.
English: When you move to your maintenance dose.............14
Danish: Når du overgår til din vedligeholdelsesdosis.............14 Hvis du har glemt at tage Uptravi..............................16
English: If you forget to take Uptravi.....................................16 If you stop taking Uptravi.........................................17 Titration diary...........................................................18
Danish: ....................................10 Nedtrapning..............................................................12
English: Your doctor will prescribe a suitable tablet strength for your maintenance dose.
Danish: Din læge vil ordinere en tablet med den for dig individuelt tilpassede styrke, som vil være din vedligeholdelsesdosis.
English: Remember to talk to your PAH doctor or nurse regularly.
Danish: Husk, at du skal være i regelmæssig kontakt med din PAH-læge eller sundhedspersonalet.
English: In the presence of 400/100 mg lopinavir/ritonavir twice daily, a strong OATP (OATP1B1 and OATP1B3) and P-gp inhibitor, exposure to selexipag increased approximately 2-fold, whereas the exposure to the active metabolite of selexipag did not change.
Danish: Ved brug af 400/100 mg lopinavir/ritonavir, en stærk OATP- (OATPB1 og OATP1B3) og P-gphæmmer, to gange dagligt, steg eksponeringen for selexipag til cirka det dobbelte, hvorimod eksponeringen for selexipags aktive metabolit var uforandret.
English: Rash Urticaria Erythema
Danish: Udslæt Urticaria Erytem
English: Revert to twice daily dosing frequency of Uptravi when co-administration of moderate CYP2C8 inhibitor is stopped (see section 4.5).
Danish: Vend tilbage til dosering med Uptravi to gange dagligt, når samtidig administration af moderate CYP2C8-hæmmere er ophørt (se pkt.
English: • Healthcare professional A4 laminated titration guide;
Danish: • Lamineret titreringsvejledning i A4-format til læger og sundhedspersonale.
English: Page 30
Danish: Side 30
English: In the presence of 600 mg rifampicin, once a day, an inducer of CYP2C8 (and UGT enzymes), the exposure to selexipag did not change, whereas exposure to the active metabolite was reduced by half.
Danish: Ved brug af 600 mg rifampicin, en induktor af CYP2C8 (og UGT-enzymer), én gang dagligt var der ingen forandring i eksponeringen for selexipag, hvorimod eksponeringen for den aktive metabolit blev reduceret til det halve.
English: Page 31
Danish: Side 31
English: Page 38
Danish: Side 38
English: Page 5
Danish: Side 5
English: Page 35
Danish: Side 35
English: Page 25
Danish: Side 25
English: If you have taken more tablets than you have been told to take, ask your doctor for advice.
Danish: Spørg lægen til råds, hvis du har taget flere tabletter, end lægen har anvist.
English: Page 23
Danish: Side 23
English: Page 24
Danish: Side 24
English: Page 39
Danish: Side 39
English: Page 36
Danish: Side 36
English: Page 33
Danish: Side 33
English: Other medicines and Uptravi
Danish: Brug af anden medicin sammen med Uptravi
English: The goal is to reach the dose that is most appropriate to treat you.
Danish: Formålet er at nå den dosis, der er mest velegnet til
English: Selexipag is hydrolysed to its active metabolite by carboxylesterases (see section 5.2).
Danish: Selexipag hydrolyseres til sin aktive metabolit via carboxylesteraser (se pkt.
English: Page 12
Danish: Side 12
English: Page 15
Danish: Side 15
English: Page 2
Danish: Side 2
English: Page 32
Danish: Side 32
English: Page 28
Danish: Side 28
English: Page 20
Danish: Side 20
English: Page 29
Danish: Side 29
English: Dose adjustment of selexipag may be required with concomitant administration of inducers of CYP2C8 (e.g., rifampicin, carbamazepine, phenytoin).
Danish: Ved samtidig administration af CYP2C8-induktorer (f.eks. rifampicin, carbamazepin, phenytoin) kan det være nødvendigt at justere dosen af selexipag.
English: Page 17
Danish: Side 17
English: Page 16
Danish: Side 16
English: Page 9
Danish: Side 9
English: Page 37
Danish: Side 37
English: Page 11
Danish: Side 11
English: Page 40
Danish: Side 40
English: Page 18
Danish: Side 18
English: In the presence of 600 mg gemfibrozil, twice a day, a strong inhibitor of CYP2C8, exposure to selexipag increased approximately 2-fold, whereas exposure to the active metabolite, the major contributor to efficacy, increased approximately 11-fold.
Danish: Ved brug af 600 mg gemfibrozil (en stærk CYP2C8-hæmmer) to gange dagligt steg eksponeringen for selexipag til cirka det dobbelte, hvorimod eksponeringen for den aktive metabolit, som bidrager væsentligt til virkningen, steg cirka 11 gange.
English: Page 22
Danish: Side 22
English: In subjects with mild (Child-Pugh class A) or moderate (Child-Pugh class B) hepatic impairment, exposure to selexipag was 2- and 4-fold higher, respectively, when compared to healthy subjects.
Danish: Eksponeringen for selexipag var hhv. 2 og 4 gange højere hos patienter med mild (Child-Pugh-klasse A) eller moderat (Child-Pugh-klasse B) leverinsufficiens end hos raske forsøgsdeltagere.
English: Anticoagulants or inhibitors of platelet aggregation
Danish: Antikoagulantia eller trombocytaggregationshæmmere
English: Page 10
Danish: Side 10
English: Page 27
Danish: Side 27
English: Page 34
Danish: Side 34
English: The mean age was 48.1 years (range 18-80 years of age), with the majority of subjects being
Danish: Den gennemsnitlige alder var 48,1 år (interval 18-80 år), og størstedelen af forsøgsdeltagerne var kaukasere (65,0 %) og kvinder (79,8 %).
English: Uptravi 200 microgram Uptravi 400 microgram Uptravi 600 microgram Uptravi 800 microgram Uptravi 1,000 microgram Uptravi 1,200 microgram Uptravi 1,400 microgram Uptravi 1,600 microgram
Danish: Uptravi 200 mikrogram Uptravi 400 mikrogram Uptravi 600 mikrogram Uptravi 800 mikrogram Uptravi 1.000 mikrogram Uptravi 1.200 mikrogram Uptravi 1.400 mikrogram Uptravi 1.600 mikrogram
English: In the presence of 400/100 mg lopinavir/ritonavir twice daily, a strong CYP3A4 inhibitor, exposure to selexipag increased approximately 2-fold, whereas the exposure to the active metabolite of selexipag did not change.
Danish: Ved brug af 400/100 mg lopinavir/ritonavir (en stærk CYP3A4-hæmmer) to gange dagligt, steg eksponeringen for selexipag til cirka det dobbelte, hvorimod eksponeringen for selexipags aktive metabolit var uforandret.
English: Individualised dose titration
Danish: Individuelt tilpasset dosistitrering
English: Diarrhoea* Vomiting * Nausea*
Danish: Mave-tarm-kanalen Diarré* Opkastning*
English: Page 19
Danish: Side 19
English: Page 14
Danish: Side 14
English: Cartons of 10 or 60 film-coated tablets, and 60 or 140 film-coated tablets (titration packs).
Danish: Uptravi 200 mikrogram filmovertrukne tabletter Kartoner med 10 eller 60 filmovertrukne tabletter og 60 eller 140 filmovertrukne tabletter (titreringspakker).
English: Page 21
Danish: Side 21
English: Page 13
Danish: Side 13
English: Page 7
Danish: Side 7
English: Page 26
Danish: Side 26
English: Page 4
Danish: Side 4
English: During dose titration some adverse reactions, reflecting the mode of action of Uptravi (such as headache, diarrhoea, nausea and vomiting, jaw pain, myalgia, pain in extremity, arthralgia, and flushing), may occur.
Danish: I forbindelse med dosistitrering kan der indtræde bivirkninger, der afspejler Uptravis virkningsmekanisme (såsom hovedpine, diarré, kvalme og opkastning, smerter i kæben, myalgi, ekstremitetssmerter, artralgi og blussen).
English: Page 6
Danish: Side 6
English: Page 3
Danish: Side 3
English: If you forget to take Uptravi, take a dose as soon as you remember, then continue to take your tablets at the usual times.
Danish: Hvis du glemmer at tage Uptravi, skal du tage en dosis, så snart du kommer i tanker om det.
English: Uptravi 400 microgram, 600 microgram, 800 microgram, 1,000 microgram, 1,200 microgram, 1,400 microgram, and 1,600 microgram film-coated tablets are supplied in blister packs of 60 tablets.
Danish: Uptravi 400 mikrogram, 600 mikrogram, 800 mikrogram, 1.000 mikrogram, 1.200 mikrogram, 1.400 mikrogram og 1.600 mikrogram filmovertrukne tabletter leveres i blisterpakninger med 60 tabletter.
English: For patients with moderate hepatic impairment (Child-Pugh class B), the starting dose of Uptravi should be 200 micrograms once daily, and increased at weekly intervals by increments of 200 micrograms given once daily until adverse reactions, reflecting the mode of action of selexipag, that cannot be tolerated or medically managed are experienced.
Danish: Denne dosis øges med ugentlige intervaller i trin af 200 mikrogram givet én gang dagligt, indtil patienten får utålelige eller medicinsk uhåndterbare bivirkninger, der afspejler selexipags virkningsmåde.
English: Anaemia Haemoglobin decreased
Danish: Anæmi Hæmoglobin nedsat
English: Selexipag is an inhibitor of platelet aggregation in vitro.
Danish: Selexipag hæmmer trombocytaggregationen in vitro.
English: Each film-coated tablet contains 200 micrograms of selexipag
Danish: Hver filmovertrukken tablet indeholder 200 mikrogram selexipag
English: Pain in jaw Myalgia
Danish: Smerter i kæben* Myalgi*
English: For a full list of side effects see package leaflet for further information.
Danish: Du kan se en komplet liste over bivirkninger i indlægssedlen.
English: Uptravi 400 microgram, 600 microgram, 800 microgram, 1,000 microgram, 1,200 microgram, 1,400 microgram, and 1,600 microgram film-coated tablets Cartons of 60 film-coated tablets.
Danish: Uptravi 400 mikrogram, 600 mikrogram, 800 mikrogram, 1.000 mikrogram, 1.200 mikrogram, 1.400 mikrogram og 1.600 mikrogram filmovertrukne tabletter Kartoner med 60 filmovertrukne tabletter.
English: Check with your doctor if you are not sure or have any questions.
Danish: Spørg lægen eller sundhedspersonalet, hvis der er noget, du er i tvivl om.
English: Both in healthy subjects and PAH patients, after oral administration, exposure at steady state to the active metabolite is approximately 3- to 4-fold higher than to the parent compound.
Danish: Ved steady state er eksponeringen for den aktive metabolit cirka 3 til 4 gange højere end eksponeringen for moderstoffet, både hos raske forsøgsdeltagere og PAH-patienter efter oral administration.
English: It acts on blood vessels in a similar way to the natural substance prostacyclin, making them relax and widen.
Danish: Det har samme afslappende og udvidende virkning på blodkarrene som det naturlige stof prostacyklin.
English: Selexipag and the active metabolite are not genotoxic on the basis of the overall evidence of conducted genotoxicity studies.
Danish: Vurderet ud fra den samlede evidens fra udførte genotoksicitetsstudier er selexipag og den aktive metabolit ikke genotoksiske.
English: Hypromellose, propylene glycol, titanium dioxide (E171), carnauba wax and iron oxides (see below).
Danish: Hypromellose, propylenglycol, titandioxid (E171), carnaubavoks og jernoxider (se nedenfor).
English: Jaw pain* Myalgia* Arthralgia* Pain in extremity*
Danish: Artralgi* Smerter i ekstremiteterne*
English: Uptravi 800 microgram film-coated tablets: Round, green, film-coated tablets with “8” marked on one side.
Danish: Uptravi 800 mikrogram filmovertrukne tabletter: Runde, grønne, filmovertrukne tabletter, der er mærket med "8" på den ene side.
English: There is no experience with Uptravi in patients undergoing dialysis (see section 5.2), therefore Uptravi should not be used in these patients.
Danish: Der er ingen erfaring med Uptravi hos patienter i dialyse (se pkt.
English: Uptravi 200 microgram tablets Uptravi 400 microgram tablets Uptravi 600 microgram tablets Uptravi 800 microgram tablets Uptravi 1,000 microgram tablets Uptravi 1,200 microgram tablets Uptravi 1,400 microgram tablets Uptravi 1,600 microgram tablets selexipag
Danish: Uptravi 200 mikrogram tabletter Uptravi 400 mikrogram tabletter Uptravi 600 mikrogram tabletter Uptravi 800 mikrogram tabletter Uptravi 1.000 mikrogram tabletter Uptravi 1.200 mikrogram tabletter Uptravi 1.400 mikrogram tabletter Uptravi 1.600 mikrogram tabletter selexipag
English: Uptravi 1,000 microgram film-coated tablets: Round, orange, film-coated tablets with “10” marked on one side.
Danish: Uptravi 1.000 mikrogram filmovertrukne tabletter: Runde, orange, filmovertrukne tabletter, der er mærket med "10" på den ene side.
English: • Patient Leaflet.
Danish: • Indlægsseddel.
English: Uptravi 800 microgram film-coated tablets Each film-coated tablet contains 800 micrograms of selexipag.
Danish: Uptravi 800 mikrogram filmovertrukne tabletter Hver filmovertrukken tablet indeholder 800 mikrogram selexipag.
English: Uptravi 800 microgram film-coated tablets Round, green, film-coated tablets with “8” debossed on one side.
Danish: Uptravi 800 mikrogram filmovertrukne tabletter Runde, grønne, filmovertrukne tabletter, der er præget med "8" på den ene side.
English: Uptravi 1,000 microgram film-coated tablets Round, orange, film-coated tablets with “10” debossed on one side.
Danish: Uptravi 1.000 mikrogram filmovertrukne tabletter Runde, orange, filmovertrukne tabletter, der er præget med "10" på den ene side.
English: Uptravi 400 microgram film-coated tablets: Round, red, film-coated tablets with “4” marked on one side.
Danish: Uptravi 400 mikrogram filmovertrukne tabletter: Runde, røde, filmovertrukne tabletter, der er mærket med "4" på den ene side.
English: Uptravi 400 microgram film-coated tablets contain iron oxide red (E172).
Danish: Uptravi 400 mikrogram filmovertrukne tabletter indeholder rød jernoxid (E172).
English: Uptravi 1,400 microgram film-coated tablets contain iron oxide yellow (E172).
Danish: Uptravi 1.400 mikrogram filmovertrukne tabletter indeholder gul jernoxid (E172).
English: Uptravi 1,600 microgram film-coated tablets: Round, brown, film-coated tablets with “16” marked on one side.
Danish: Uptravi 1.600 mikrogram filmovertrukne tabletter: Runde, brune, filmovertrukne tabletter, der er mærket med "16" på den ene side.
English: Uptravi 800 microgram film-coated tablets contain iron oxide yellow and iron oxide black (E172).
Danish: Uptravi 800 mikrogram filmovertrukne tabletter indeholder gul jernoxid og sort jernoxid (E172).
English: Uptravi 800 microgram film-coated tablets.
Danish: Uptravi 800 mikrogram filmovertrukne tabletter.
English: Uptravi 200 microgram film-coated tablets Each film-coated tablet contains 200 micrograms of selexipag.
Danish: Uptravi 200 mikrogram filmovertrukne tabletter Hver filmovertrukken tablet indeholder 200 mikrogram selexipag.
English: Uptravi 400 microgram film-coated tablets Round, red, film-coated tablets with “4” debossed on one side.
Danish: Uptravi 400 mikrogram filmovertrukne tabletter Runde, røde, filmovertrukne tabletter, der er præget med "4" på den ene side.
English: Uptravi 200 microgram film-coated tablets contain iron oxide yellow (E172).
Danish: Uptravi 200 mikrogram filmovertrukne tabletter indeholder gul jernoxid (E172).
English: Uptravi 1,000 microgram film-coated tablets Each film-coated tablet contains 1,000 micrograms of selexipag.
Danish: Uptravi 1.000 mikrogram filmovertrukne tabletter Hver filmovertrukken tablet indeholder 1.000 mikrogram selexipag.
English: Uptravi 200 microgram film-coated tablets.
Danish: Uptravi 200 mikrogram filmovertrukne tabletter.
English: Uptravi 1,200 microgram film-coated tablets Each film-coated tablet contains 1,200 micrograms of selexipag.
Danish: Uptravi 1.200 mikrogram filmovertrukne tabletter Hver filmovertrukken tablet indeholder 1.200 mikrogram selexipag.
English: If you miss a dose, take the dose as soon as you remember, then continue to take your tablets at the usual times.
Danish: Hvis du glemmer en dosis, skal du tage den, så snart du kommer i tanker om det.
English: Uptravi 200 microgram film-coated tablets Uptravi 400 microgram film-coated tablets Uptravi 600 microgram film-coated tablets Uptravi 800 microgram film-coated tablets Uptravi 1,000 microgram film-coated tablets Uptravi 1,200 microgram film-coated tablets Uptravi 1,400 microgram film-coated tablets Uptravi 1,600 microgram film-coated tablets selexipag
Danish: Uptravi 200 mikrogram filmovertrukne tabletter Uptravi 400 mikrogram filmovertrukne tabletter Uptravi 600 mikrogram filmovertrukne tabletter Uptravi 800 mikrogram filmovertrukne tabletter Uptravi 1.000 mikrogram filmovertrukne tabletter Uptravi 1.200 mikrogram filmovertrukne tabletter Uptravi 1.400 mikrogram filmovertrukne tabletter Uptravi 1.600 mikrogram filmovertrukne tabletter
English: Uptravi 400 microgram film-coated tablets Each film-coated tablet contains 400 micrograms of selexipag.
Danish: Uptravi 400 mikrogram filmovertrukne tabletter Hver filmovertrukken tablet indeholder 400 mikrogram selexipag.
English: Uptravi 400 microgram film-coated tablets.
Danish: Uptravi 400 mikrogram filmovertrukne tabletter.
English: Uptravi 1,200 microgram film-coated tablets: Round, dark-violet, film-coated tablets with “12” marked on one side.
Danish: Uptravi 1.200 mikrogram filmovertrukne tabletter: Runde, mørkelilla, filmovertrukne tabletter, der er mærket med "12" på den ene side.
English: Uptravi 1,000 microgram film-coated tablets.
Danish: Uptravi 1.000 mikrogram filmovertrukne tabletter.
English: Uptravi 200 microgram film-coated tablets: Round, light-yellow, film-coated tablets with “2” marked on one side.
Danish: Uptravi 200 mikrogram filmovertrukne tabletter: Runde, lysegule, filmovertrukne tabletter, der er mærket med "2" på den ene side.
English: Uptravi 1,400 microgram film-coated tablets.
Danish: Uptravi 1.400 mikrogram filmovertrukne tabletter.
English: Uptravi 1,000 microgram film-coated tablets contain iron oxide red and iron oxide yellow (E172).
Danish: Uptravi 1.000 mikrogram filmovertrukne tabletter indeholder rød jernoxid og gul jernoxid (E172).
English: Uptravi 600 microgram film-coated tablets contain iron oxide red and iron oxide black (E172).
Danish: Uptravi 600 mikrogram filmovertrukne tabletter indeholder rød jernoxid og sort jernoxid (E172).
English: Uptravi 1,200 microgram film-coated tablets contain iron oxide black and iron oxide red (E172).
Danish: Uptravi 1.200 mikrogram filmovertrukne tabletter indeholder sort jernoxid og rød jernoxid (E172).
English: Uptravi 1,200 microgram film-coated tablets.
Danish: Uptravi 1.200 mikrogram filmovertrukne tabletter.
English: Uptravi 1,600 microgram film-coated tablets contain iron oxide black, iron oxide red and iron oxide yellow (E172).
Danish: Uptravi 1.600 mikrogram filmovertrukne tabletter indeholder sort jernoxid, rød jernoxid og gul jernoxid (E172).
English: Uptravi 1,600 microgram film-coated tablets Round, brown, film-coated tablets with “16” debossed on one side.
Danish: Uptravi 1.600 mikrogram filmovertrukne tabletter Runde, brune, filmovertrukne tabletter, der er præget med "16" på den ene side.
English: Uptravi 600 microgram film-coated tablets: Round, light-violet, film-coated tablets with “6” marked on one side.
Danish: Uptravi 600 mikrogram filmovertrukne tabletter: Runde, lyselilla, filmovertrukne tabletter, der er mærket med "6" på den ene side.
English: Uptravi 1,400 microgram film-coated tablets: Round, dark-yellow, film-coated tablets with “14” marked on one side.
Danish: Uptravi 1.400 mikrogram filmovertrukne tabletter: Runde, mørkegule, filmovertrukne tabletter, der er mærket med "14" på den ene side.
English: Uptravi 600 microgram film-coated tablets Each film-coated tablet contains 600 micrograms of selexipag.
Danish: Uptravi 600 mikrogram filmovertrukne tabletter Hver filmovertrukken tablet indeholder 600 mikrogram selexipag.
English: Pulmonary haemodynamics
Danish: Pulmonal hæmodynamik
English: Uptravi 600 microgram film-coated tablets.
Danish: Uptravi 600 mikrogram filmovertrukne tabletter.